Jaguar Health, Inc.
Jaguar Health, Inc. (JAGX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · JAGX · as of Jun 8, 2026
Key Statistics
Explore Jaguar Health, Inc. Data
jagx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 100.0%
The JAGX analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $12.98, representing +375.46% upside from the current price of $2.73.
Competitors & Peers
jagx competitorsJAGX
BDRX
CANF
CLDI
CNSP
GNPXStock Performance
Full HistoryAbout Jaguar Health, Inc.
Jaguar Health, Inc. a commercial-stage pharmaceutical firm, specializes in developing prescription therapies for both human and animal patients afflicted by gastrointestinal ailments, particularly ch…
what is jaguar health, inc. · jagx stock overview · jaguar health, inc. company profile · who is jaguar health, inc. ceo · jagx NASDAQ · jaguar health, inc. headquarters · jaguar health, inc. business segments
About Stock Overview & Key Data
Jaguar Health, Inc. (JAGX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 12, 2015. As of the latest trading session, JAGX stock price is $2.73, with a market capitalization of $181,927. The stock has returned -97.95% over the past 12 months and -91.62% year-to-date.
According to 5 Wall Street analysts, the consensus rating for Jaguar Health, Inc. stock is Buy, with an average 12-month price target of $12.98. In fiscal year 2025, Jaguar Health, Inc. reported revenue of $11.5M and net income of -$53.6M. For detailed data — including Jaguar Health, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Jaguar Health, Inc. (JAGX) stock price is $2.73. The stock is traded on NASDAQ under the ticker symbol JAGX. The 52-week range is $2.53 – $144.55.